These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1381204)

  • 1. Pyridoxal-5'-phosphate inhibits the polymerase activity of a recombinant RNAase H-deficient mutant of HIV-1 reverse transcriptase.
    Moen LK; Bathurst IC; Barr PJ
    AIDS Res Hum Retroviruses; 1992 May; 8(5):597-604. PubMed ID: 1381204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site studies of human immunodeficiency virus reverse transcriptase.
    Mitchell LL; Cooperman BS
    Biochemistry; 1992 Aug; 31(33):7707-13. PubMed ID: 1380826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ribonuclease H activity of HIV-1 reverse transcriptase: further biochemical characterization and search of inhibitors.
    Andréola ML; Tharaud D; Litvak S; Tarrago-Litvak L
    Biochimie; 1993; 75(1-2):127-34. PubMed ID: 7684932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical analysis of human immunodeficiency virus-1 reverse transcriptase containing a mutation at position lysine 263.
    Martin JL; Wilson JE; Furfine ES; Hopkins SE; Furman PA
    J Biol Chem; 1993 Feb; 268(4):2565-70. PubMed ID: 7679098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basic loop of the RNase H domain of MLV RT is important both for RNase H and for polymerase activity.
    Boyer PL; Gao HQ; Frank P; Clark PK; Hughes SH
    Virology; 2001 Mar; 282(1):206-13. PubMed ID: 11259203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities.
    Post K; Guo J; Kalman E; Uchida T; Crouch RJ; Levin JG
    Biochemistry; 1993 Jun; 32(21):5508-17. PubMed ID: 7684924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.
    Boyer PL; Ferris AL; Clark P; Whitmer J; Frank P; Tantillo C; Arnold E; Hughes SH
    J Mol Biol; 1994 Oct; 243(3):472-83. PubMed ID: 7525967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
    Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
    J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
    Tisdale M; Schulze T; Larder BA; Moelling K
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the RNA-directed DNA polymerase activity of a recombinant HIV-1 p51 reverse transcriptase by a p15 ribonuclease H domain.
    Evans DB; Kézdy FJ; Tarpley G; Sharma SK
    Biotechnol Appl Biochem; 1993 Feb; 17(1):91-102. PubMed ID: 7679907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate binding in human immunodeficiency virus reverse transcriptase. An analysis of pyridoxal 5'-phosphate sensitivity and identification of lysine 263 in the substrate-binding domain.
    Basu A; Tirumalai RS; Modak MJ
    J Biol Chem; 1989 May; 264(15):8746-52. PubMed ID: 2470747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase.
    Cirino NM; Cameron CE; Smith JS; Rausch JW; Roth MJ; Benkovic SJ; Le Grice SF
    Biochemistry; 1995 Aug; 34(31):9936-43. PubMed ID: 7543283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization.
    Ghosh M; Jacques PS; Rodgers DW; Ottman M; Darlix JL; Le Grice SF
    Biochemistry; 1996 Jul; 35(26):8553-62. PubMed ID: 8679616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase.
    Evans DB; Fan N; Swaney SM; Tarpley WG; Sharma SK
    J Biol Chem; 1994 Aug; 269(34):21741-7. PubMed ID: 7520442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the RNA- and DNA-dependent DNA polymerase activities of point mutants of HIV-1 reverse transcriptase lacking ribonuclease H activity.
    Dudding LR; Nkabinde NC; Mizrahi V
    Biochemistry; 1991 Oct; 30(43):10498-506. PubMed ID: 1718422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
    Hizi A; Shaharabany M; Tal R; Hughes SH
    J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
    Sevilya Z; Loya S; Adir N; Hizi A
    Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
    Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
    Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1.
    Loya S; Tal R; Hughes SH; Hizi A
    J Biol Chem; 1992 Jul; 267(20):13879-83. PubMed ID: 1378433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.